Experts Want Labels For Pfizer, Moderna COVID-19 Vaccines Updated To Acknowledge Limitations

“A coalition of experts is calling for U.S. officials to update the labels for the Pfizer and Moderna COVID-19 vaccines to acknowledge limitations to clinical trials, including stating clearly that the phase III trials that led to clearance did not provide evidence of efficacy against death. ‘Incomplete, inaccurate, or misleading labeling of any medical product can negatively impact the health and safety of Americans, with global ramifications considering the international importance of FDA decisions,’ Peter Doshi, an associate professor at the University of Maryland School of Pharmacy whose expertise includes clinical trials, and eight other experts wrote in the petition.”

https://www.zerohedge.com/medical/experts-want-labels-pfizer-moderna-covid-19-vaccines-updated-acknowledge-limitations

https://www.documentcloud.org/documents/23599228-caalm-citizen-petition-to-fda

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: